Market News

Taylor Morrison Home (TMHC) Touches $27.75 High on Jan, 13; Icu Medical Has 0.86 Sentiment

The stock of Taylor Morrison Home Corporation (NYSE:TMHC) reached all time high today, Jan, 13 and still has $29.42 target or 6.00% above today’s $27.75 share price. This indicates more upside for the $3.32B company. This technical setup was reported by Barchart.com. If the $29.42 PT is reached, the company will be worth $199.14M more. The stock decreased 2.32% or $0.66 during the last trading session, reaching $27.75. About 9.91 million shares traded or 576.26% up from the average. Taylor Morrison Home Corporation (NYSE:TMHC) has risen 72.45% since January 13, 2017 and is uptrending. It has outperformed by 55.75% the S&P500.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide. The company has market cap of $4.44 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patientÂ’s vein for use in hospitals and ambulatory clinics. It has a 155.77 P/E ratio. The companyÂ’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

Since October 4, 2017, it had 0 buys, and 1 insider sale for $456,568 activity. Cone C. David sold $456,568 worth of stock.

Investors sentiment decreased to 1.18 in 2017 Q3. Its down 2.01, from 3.19 in 2017Q2. It worsened, as 35 investors sold Taylor Morrison Home Corporation shares while 42 reduced holdings. 21 funds opened positions while 70 raised stakes. 69.48 million shares or 50.77% less from 141.13 million shares in 2017Q2 were reported. Panagora Asset invested 0.01% of its portfolio in Taylor Morrison Home Corporation (NYSE:TMHC). Alpine Woods Investors Ltd Limited Liability Company invested 0.23% of its portfolio in Taylor Morrison Home Corporation (NYSE:TMHC). Rhumbline Advisers has 0% invested in Taylor Morrison Home Corporation (NYSE:TMHC) for 71,295 shares. Switzerland-based Swiss Bancshares has invested 0% in Taylor Morrison Home Corporation (NYSE:TMHC). Barclays Public Limited Company holds 14,754 shares or 0% of its portfolio. Clarivest Asset Mngmt Ltd holds 204,251 shares or 0.1% of its portfolio. Koch Industry invested in 0.07% or 12,857 shares. Schroder Inv Management Group has invested 0.01% in Taylor Morrison Home Corporation (NYSE:TMHC). Cubist Systematic Strategies Ltd Limited Liability Company holds 95,550 shares. Greenhaven Assocs Inc holds 0.84% of its portfolio in Taylor Morrison Home Corporation (NYSE:TMHC) for 2.53M shares. Check Cap Mgmt Inc Ca invested 0.02% of its portfolio in Taylor Morrison Home Corporation (NYSE:TMHC). Jpmorgan Chase And holds 0.01% in Taylor Morrison Home Corporation (NYSE:TMHC) or 2.12M shares. Paragon Capital Mngmt Limited invested 0.08% in Taylor Morrison Home Corporation (NYSE:TMHC). Moreover, Vanguard Grp Inc Inc has 0.01% invested in Taylor Morrison Home Corporation (NYSE:TMHC). Grp Inc Inc holds 0% of its portfolio in Taylor Morrison Home Corporation (NYSE:TMHC) for 47,137 shares.

Analysts await Taylor Morrison Home Corporation (NYSE:TMHC) to report earnings on January, 29. They expect $0.66 EPS, up 1.54% or $0.01 from last year’s $0.65 per share. TMHC’s profit will be $78.94 million for 10.51 P/E if the $0.66 EPS becomes a reality. After $0.45 actual EPS reported by Taylor Morrison Home Corporation for the previous quarter, Wall Street now forecasts 46.67% EPS growth.

Among 11 analysts covering Taylor Morrison Home Corporation (NYSE:TMHC), 6 have Buy rating, 0 Sell and 5 Hold. Therefore 55% are positive. Taylor Morrison Home Corporation had 30 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Deutsche Bank on Tuesday, August 9 with “Buy”. The stock of Taylor Morrison Home Corporation (NYSE:TMHC) has “Buy” rating given on Tuesday, February 9 by Deutsche Bank. The firm has “Buy” rating by Deutsche Bank given on Monday, September 21. As per Monday, August 7, the company rating was maintained by Deutsche Bank. Citigroup maintained the stock with “Neutral” rating in Thursday, August 4 report. The stock of Taylor Morrison Home Corporation (NYSE:TMHC) has “Buy” rating given on Thursday, August 6 by Sterne Agee CRT. The company was downgraded on Thursday, August 4 by Susquehanna. The firm has “Neutral” rating by Wedbush given on Tuesday, September 20. The stock of Taylor Morrison Home Corporation (NYSE:TMHC) earned “Equal Weight” rating by Barclays Capital on Friday, January 6. The stock has “Market Perform” rating by Wells Fargo on Thursday, September 29.

Taylor Morrison Home Corporation operates as a public homebuilder in the United States. The company has market cap of $3.32 billion. The firm designs, builds, and sells single-family detached and attached homes; and develops lifestyle and master planned communities. It has a 20.27 P/E ratio. It operates under the Taylor Morrison and Darling Homes brands in Arizona, California, Colorado, Florida, Georgia, Illinois, North Carolina and Texas.

Pura Vida Investments Llc holds 5.35% of its portfolio in ICU Medical, Inc. for 57,500 shares. Elk Creek Partners Llc owns 188,348 shares or 2.2% of their US portfolio. Moreover, Redmile Group Llc has 1.85% invested in the company for 201,750 shares. The California-based Lyon Street Capital Llc has invested 1.34% in the stock. Gam Holding Ag, a Switzerland-based fund reported 155,000 shares.

Analysts await ICU Medical, Inc. (NASDAQ:ICUI) to report earnings on March, 7. They expect $0.83 earnings per share, up 53.70% or $0.29 from last year’s $0.54 per share. ICUI’s profit will be $16.43 million for 67.47 P/E if the $0.83 EPS becomes a reality. After $0.01 actual earnings per share reported by ICU Medical, Inc. for the previous quarter, Wall Street now forecasts 8,200.00% EPS growth.

Since January 1, 0001, it had 0 insider purchases, and 8 insider sales for $27.49 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *